Email updates

Keep up to date with the latest news and content from BMC Health Services Research and BioMed Central.

Open Access Research article

Trends and changes in prescription opioid analgesic dispensing in Canada 2005–2012: an update with a focus on recent interventions

Benedikt Fischer123*, Wayne Jones1 and Jürgen Rehm2345

  • * Corresponding author: Benedikt Fischer bfischer@sfu.ca

  • † Equal contributors

Author Affiliations

1 Centre for Applied Research in Mental Health and Addiction (CARMHA), Faculty of Health Sciences, Simon Fraser University, Vancouver, Canada

2 Social and Epidemiological Research, Centre for Addiction and Mental Health (CAMH), Toronto, Canada

3 Department of Psychiatry, University of Toronto, Toronto, Canada

4 Dalla Lana School of Population Health, University of Toronto, Toronto, Canada

5 Technische Universität, Dresden, Germany

For all author emails, please log on.

BMC Health Services Research 2014, 14:90  doi:10.1186/1472-6963-14-90

Published: 26 February 2014

Abstract

Background

Prescription opioid analgesic (POA) utilization has steeply increased globally, yet is far higher in established market economies than elsewhere. Canada features the world’s second-highest POA consumption rates. Following increases in POA-related harm, several POA control interventions have been implemented since 2010.

Methods

We examined trends and patterns in POA dispensing in Canada by province for 2005–2012, including a focus on the potential effects of interventions. Data on annual dispensing of individual POA formulations – categorized into ‘weak opioids’ and ‘strong opioids’ – from a representative sub-sample of 5,700 retail pharmacies across Canada (from IMS Brogan’s Compuscript) were converted into Defined Daily Doses (DDD), and examined intra- and inter-provincially as well as for Canada (total).

Results

Total POA dispensing – driven by strong opioids – increased across Canada until 2011; four provinces indicated decreases in strong opioid dispensing; seven provinces indicated decreases specifically in oxycodone dispensing, 2011–2012. The dispensing ratio weak/strong opioids decreased substantively. Major inter-provincial differences in POA dispensing levels and qualitative patterns of POA formulations dispensed persisted. Previous increasing trends in POA dispensing were reversed in select provinces 2011–2012, coinciding with POA-related interventions.

Conclusions

Further examinations regarding the sustained nature, drivers and consequences of the recent trend changes in POA dispensing – including possible ‘substitution effects’ for oxycodone reductions – are needed.

Keywords:
Prescription opioids; Oxycodone; Health policy; Canada; Population health